Mallis R, Brazin K, Duke-Cohan J, Akitsu A, Stephens H, Chang-Gonzalez A
Immunol Rev. 2025; 329(1):e13432.
PMID: 39745432
PMC: 11744257.
DOI: 10.1111/imr.13432.
Sureshchandra S, Henderson J, Levendosky E, Bhattacharyya S, Kastenschmidt J, Sorn A
bioRxiv. 2024; .
PMID: 39229002
PMC: 11370363.
DOI: 10.1101/2024.08.17.608295.
Shi Y, Strasser A, Green D, Latz E, Mantovani A, Melino G
Cell Mol Immunol. 2024; 21(7):790-797.
PMID: 38822079
PMC: 11214623.
DOI: 10.1038/s41423-024-01168-4.
Klebanoff C, Chandran S, Baker B, Quezada S, Ribas A
Nat Rev Drug Discov. 2023; 22(12):996-1017.
PMID: 37891435
PMC: 10947610.
DOI: 10.1038/s41573-023-00809-z.
Shin S, McNagny K
Clin Exp Immunol. 2023; 213(1):10-12.
PMID: 37326969
PMC: 10324545.
DOI: 10.1093/cei/uxad067.
Local γδ T cells: translating promise to practice in cancer immunotherapy.
Zlatareva I, Wu Y
Br J Cancer. 2023; 129(3):393-405.
PMID: 37311978
PMC: 10403623.
DOI: 10.1038/s41416-023-02303-0.
Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties.
Elsayed A, Pellegrino C, Pluss L, Peissert F, Benz R, Ulrich F
MAbs. 2023; 15(1):2220839.
PMID: 37288872
PMC: 10251795.
DOI: 10.1080/19420862.2023.2220839.
Antigen-specific and cross-reactive T cells in protection and disease.
Jiang N, Malone M, Chizari S
Immunol Rev. 2023; 316(1):120-135.
PMID: 37209375
PMC: 10524458.
DOI: 10.1111/imr.13217.
Organoids as an Enabler of Precision Immuno-Oncology.
Zhao J, Fong A, Seow S, Toh H
Cells. 2023; 12(8).
PMID: 37190074
PMC: 10136954.
DOI: 10.3390/cells12081165.
TCR sequencing: applications in immuno-oncology research.
Sanroman A, Joshi K, Au L, Chain B, Turajlic S
Immunooncol Technol. 2023; 17:100373.
PMID: 36908996
PMC: 9996383.
DOI: 10.1016/j.iotech.2023.100373.
Different sea urchin RAG-like genes were domesticated to carry out different functions.
Yakovenko I, Tobi D, Ner-Gaon H, Oren M
Front Immunol. 2023; 13:1066510.
PMID: 36726993
PMC: 9885083.
DOI: 10.3389/fimmu.2022.1066510.
Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response.
Wang D, Wu X, Sun Y
Signal Transduct Target Ther. 2022; 7(1):331.
PMID: 36123348
PMC: 9485144.
DOI: 10.1038/s41392-022-01136-2.
Enrichment of human Vγ9Vδ2 T lymphocytes by magnetic poly(divinylbenzene--glycidyl methacrylate) colloidal particles conjugated with specific antibody.
Sawaisorn P, Tangchaikeeree T, Polpanich D, Midoeng P, Udomsangpetch R, Elaissari A
RSC Adv. 2022; 8(26):14393-14400.
PMID: 35540746
PMC: 9079956.
DOI: 10.1039/c8ra01468j.
Transplant Tolerance, Not Only Clonal Deletion.
Hall B, Verma N, Tran G, Hodgkinson S
Front Immunol. 2022; 13:810798.
PMID: 35529847
PMC: 9069565.
DOI: 10.3389/fimmu.2022.810798.
Genetic Modification of T Cells for the Immunotherapy of Cancer.
Quinn S, Lenart N, Dronzek V, Scurti G, Hossain N, Nishimura M
Vaccines (Basel). 2022; 10(3).
PMID: 35335089
PMC: 8949949.
DOI: 10.3390/vaccines10030457.
Recent advances in cancer immunotherapy.
Sun Q, Melino G, Amelio I, Jiang J, Wang Y, Shi Y
Discov Oncol. 2022; 12(1):27.
PMID: 35201440
PMC: 8777500.
DOI: 10.1007/s12672-021-00422-9.
On the relationship between extant innate immune receptors and the evolutionary origins of jawed vertebrate adaptive immunity.
Dornburg A, Yoder J
Immunogenetics. 2022; 74(1):111-128.
PMID: 34981186
DOI: 10.1007/s00251-021-01232-7.
Immunology 101: fundamental immunology for the practicing hematologist.
Carty S
Hematology Am Soc Hematol Educ Program. 2021; 2021(1):281-286.
PMID: 34889423
PMC: 8791153.
DOI: 10.1182/hematology.2021000260.
Identification and Characterization of Antigen-Specific CD8 T Cells Using Surface-Trapped TNF-α and Single-Cell Sequencing.
Abdulhaqq S, Ventura A, Reed J, Bashirova A, Bateman K, McDonald E
J Immunol. 2021; 207(12):2913-2921.
PMID: 34810222
PMC: 9124229.
DOI: 10.4049/jimmunol.2100535.
Building on Synthetic Immunology and T Cell Engineering: A Brief Journey Through the History of Chimeric Antigen Receptors.
Abken H
Hum Gene Ther. 2021; 32(19-20):1011-1028.
PMID: 34405686
PMC: 10112879.
DOI: 10.1089/hum.2021.165.